P. Chérin

763 total citations
26 papers, 500 citations indexed

About

P. Chérin is a scholar working on Epidemiology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, P. Chérin has authored 26 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 7 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in P. Chérin's work include Inflammatory Myopathies and Dermatomyositis (11 papers), Whipple's Disease and Interleukins (3 papers) and Systemic Sclerosis and Related Diseases (3 papers). P. Chérin is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (11 papers), Whipple's Disease and Interleukins (3 papers) and Systemic Sclerosis and Related Diseases (3 papers). P. Chérin collaborates with scholars based in France, Switzerland and Canada. P. Chérin's co-authors include François‐Jérôme Authier, M. Hamidou, Jean‐Yves Grolleau, C. Agard, Pascal Laforêt, S. Herson, M Coquet, J.M. Mussini, Michel Fardeau and Dominique Figarella‐Branger and has published in prestigious journals such as The Lancet, Journal of Neurology Neurosurgery & Psychiatry and Intensive Care Medicine.

In The Last Decade

P. Chérin

24 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Chérin France 9 281 119 89 84 80 26 500
J.M. Mussini France 10 215 0.8× 132 1.1× 50 0.6× 164 2.0× 48 0.6× 16 528
G.M. Kavanagh United Kingdom 13 140 0.5× 116 1.0× 102 1.1× 27 0.3× 142 1.8× 34 488
Yigal Barak Israel 13 117 0.4× 58 0.5× 132 1.5× 127 1.5× 33 0.4× 26 673
Calista Long United Kingdom 11 162 0.6× 88 0.7× 75 0.8× 82 1.0× 107 1.3× 26 688
Ziv Paz Israel 13 108 0.4× 208 1.7× 218 2.4× 66 0.8× 51 0.6× 29 617
Arzu Ataseven Türkiye 13 113 0.4× 105 0.9× 152 1.7× 75 0.9× 61 0.8× 81 607
Suceena Alexander India 13 49 0.2× 99 0.8× 118 1.3× 93 1.1× 54 0.7× 54 618
Seray Külcü Çakmak Türkiye 15 165 0.6× 125 1.1× 108 1.2× 48 0.6× 83 1.0× 87 693
Meral Ekşioğlu Türkiye 14 133 0.5× 93 0.8× 153 1.7× 84 1.0× 32 0.4× 65 727
Paul Devakar Yesudian United Kingdom 13 144 0.5× 97 0.8× 56 0.6× 33 0.4× 90 1.1× 74 538

Countries citing papers authored by P. Chérin

Since Specialization
Citations

This map shows the geographic impact of P. Chérin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Chérin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Chérin more than expected).

Fields of papers citing papers by P. Chérin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Chérin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Chérin. The network helps show where P. Chérin may publish in the future.

Co-authorship network of co-authors of P. Chérin

This figure shows the co-authorship network connecting the top 25 collaborators of P. Chérin. A scholar is included among the top collaborators of P. Chérin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Chérin. P. Chérin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chérin, P., et al.. (2012). Toxicité aiguë des pesticides chez l’homme. 4(2). 68–74. 6 indexed citations
2.
Chérin, P., et al.. (2010). Immunoglobulines : protéines aux potentiels thérapeutiques multiples dans les pathologies auto-immunes. La Revue de Médecine Interne. 31(9). H12–H16. 1 indexed citations
3.
Dion, Élisabeth & P. Chérin. (2004). Apport de l'IRM musculaire dans les myopathies inflammatoires. La Revue de Médecine Interne. 25(6). 435–441. 8 indexed citations
4.
Hamidou, M., et al.. (2003). Antisynthetase syndrome. Joint Bone Spine. 70(3). 161–168. 105 indexed citations
5.
Chérin, P., et al.. (2003). P440 Aetiology of persistently elevated creatine kinase levels following discontinuation of Statin drugs. European Journal of Internal Medicine. 14. S155–S155.
6.
Chérin, P. & Romain K. Gherardi. (2000). Macrophagic myofasciitis. Current Rheumatology Reports. 2(3). 196–200. 13 indexed citations
7.
Chérin, P., François‐Jérôme Authier, Romain K. Gherardi, et al.. (2000). Gallium-67 scintigraphy in macrophagic myofasciitis. Arthritis & Rheumatism. 43(7). 1520–1526. 36 indexed citations
8.
Chérin, P. & S. Herson. (1999). Les immunoglobulines intraveineuses dans les polymyosites et les dermatomyosites. La Revue de Médecine Interne. 20. 436s–439s. 6 indexed citations
9.
Chérin, P., Pascal Laforêt, Romain K. Gherardi, et al.. (1999). La myofasciite à macrophages: description, hypothèses étiopathogéniques. La Revue de Médecine Interne. 20(6). 483–489. 17 indexed citations
10.
Chérin, P.. (1999). Muscle, fatigue, sport et infection. La Revue de Médecine Interne. 20(9). 794–803. 2 indexed citations
11.
Chérin, P., Romain K. Gherardi, M Coquet, et al.. (1999). Myofasciite à macrophages: rôle des vaccins aluminiques?. La Revue de Médecine Interne. 20. 576s–576s. 2 indexed citations
12.
Coquet, M, P. Chérin, François‐Jérôme Authier, et al.. (1998). Macrophagic myofasciitis: an emerging entity. The Lancet. 352(9125). 347–352. 169 indexed citations
13.
Pautas, Éric, et al.. (1998). Cerebral Erdheim-Chester disease: report of two cases with progressive cerebellar syndrome with dentate abnormalities on magnetic resonance imaging. Journal of Neurology Neurosurgery & Psychiatry. 65(4). 597–599. 28 indexed citations
14.
Généreau, T, N Peyri, M Bérard, et al.. (1998). Human neutrophil elastase in temporal (giant cell) arteritis: plasma and immunohistochemical studies.. PubMed. 25(4). 710–3. 6 indexed citations
15.
Chérin, P., S. Herson, Marie‐Claude Crevon, et al.. (1996). Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis.. PubMed. 23(7). 1135–42. 50 indexed citations
16.
Brivet, F., et al.. (1994). Hyperchloremic acidosis during grand mal seizure lactic acidosis. Intensive Care Medicine. 20(1). 27–31. 15 indexed citations
17.
Fautrel, Bruno, P. Chérin, G. Tertian, et al.. (1993). Leucémie lymphoïde chronique, léiomyoblastome, vascularite thrombosante et anticorps anticardiolipine: à propos d'un cas. La Revue de Médecine Interne. 14(3). 171–173. 4 indexed citations
18.
Cacoub, P., J.C. Pietté, B. Wechsler, et al.. (1993). Hypertension artérielle maligne par lésion de l'artère rénale au cours du syndrome des antiphospholipides associé au lupus. La Revue de Médecine Interne. 14(6). 424–424. 1 indexed citations
19.
Chérin, P., Jean‐François Delfraissy, O Blétry, J Dormont, & P Godeau. (1991). Les manifestations pleuropulmonaires du lupus érythémateux systémique. La Revue de Médecine Interne. 12(5). 355–362. 7 indexed citations
20.
Chérin, P., Jean Marc Ziza, Jean-Denis Larédo, O Blétry, & P Godeau. (1990). Un diagnostic à connaître : la fracture de contrainte du sacrum. La Revue de Médecine Interne. 11(2). 163–164. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026